Torrent Pharmaceuticals Limited has informed the Exchange about Investor Presentation
07th November, 2025
The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1st Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)
The Manager – Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051 (NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub.: Presentation to analysts on unaudited Consolidated Financial Results for the quarter
and half year ended 30th September, 2025
The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2025 to be made to analysts is enclosed for your records.
Thanking you,
Yours Sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN M. TRIVEDI COMPANY SECRETARY
Encl: A/a
___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED CIN: L24230GJ1972PLC002126 Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com
Q2 FY 2025-26
Revenues: Summary
1
Revenue: Summary
Revenues (Rs cr)
Q2 FY26
Q2 FY25
India
United States
Germany
Brazil
Others
Total
1820
1632
337
303
318
524
268
288
263
438
3302
2889
Gr%
12%
26%
5%
21%
20%
14%
2
Revenue: Summary
Revenues (Rs cr)
H1 FY26
H1 FY25
India
United States
Germany
Brazil
Others
Total
3631
646
612
536
1055
6480
3267
527
572
459
923
5748
Gr%
11%
23%
7%
17%
14%
13%
3